126 related articles for article (PubMed ID: 10374377)
21. Serum ferritin level after resection of hepatocellular carcinoma. Correlation with alpha-fetoprotein level.
Nagasue N; Yukaya H; Chang YC; Ogawa Y
Cancer; 1986 May; 57(9):1820-3. PubMed ID: 2420438
[TBL] [Abstract][Full Text] [Related]
22. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
Peng YC; Chan CS; Chen GH
Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187
[TBL] [Abstract][Full Text] [Related]
23. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance].
Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1060-3. PubMed ID: 15498320
[TBL] [Abstract][Full Text] [Related]
24. EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer.
Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
Hepatogastroenterology; 2004; 51(55):136-41. PubMed ID: 15011849
[TBL] [Abstract][Full Text] [Related]
25. [Tumor markers in focal and diffuse liver diseases].
Kasatkin IuN; Ametov AS; Mit'kov VV; Sevast'ianov SI; Zarudin VV
Med Radiol (Mosk); 1984 Apr; 29(4):39-43. PubMed ID: 6201693
[TBL] [Abstract][Full Text] [Related]
26. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.
Nakamura S; Nouso K; Sakaguchi K; Ito YM; Ohashi Y; Kobayashi Y; Toshikuni N; Tanaka H; Miyake Y; Matsumoto E; Shiratori Y
Am J Gastroenterol; 2006 Sep; 101(9):2038-43. PubMed ID: 16848811
[TBL] [Abstract][Full Text] [Related]
28. Differential tumor markers and hepatitis markers profile in liver tumors.
Khalifa A; Mady EA; Abadeer N; Kamal A
Anticancer Res; 1999; 19(4A):2495-500. PubMed ID: 10470181
[TBL] [Abstract][Full Text] [Related]
29. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.
Tada T; Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kitabatake S; Kuzuya T; Nonogaki K; Shimizu J; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J; Satomura S
Liver Int; 2005 Aug; 25(4):848-53. PubMed ID: 15998436
[TBL] [Abstract][Full Text] [Related]
30. Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases.
Lamerz R; Runge M; Stieber P; Meissner E
Anticancer Res; 1999; 19(4A):2489-93. PubMed ID: 10470180
[TBL] [Abstract][Full Text] [Related]
31. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD
J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668
[TBL] [Abstract][Full Text] [Related]
32. [Subject diagnostic value of detecting a1pha-fetoprotein variants with a new microspincolumn method in hepatocellular carcinoma].
Xu AF; Wang MC; Sui DM; Yuan YH; Chen G; Lou GQ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):67-9. PubMed ID: 17429541
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of clinical significance of isoferritin by development of new monoclonal antibodies specific for acidic isoferritin.
You SY; Zhang CY; Yi XP; Huang W
Hybridoma; 2001 Aug; 20(4):243-8. PubMed ID: 11604110
[TBL] [Abstract][Full Text] [Related]
34. [Radioimmunological determination of the level of serum ferritin in liver diseases].
Mitkov VV; Kasatkin IuI; Ametov AS; Larina IM; Toritsina LK
Med Radiol (Mosk); 1983 Apr; 28(4):62-5. PubMed ID: 6835075
[TBL] [Abstract][Full Text] [Related]
35. [Relationship of serum iron and ferritin with the indicators for hepatic fibrosis].
Huang CW; Bai L; Cai JJ; Guo W; Lan L
Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):466-8. PubMed ID: 12754132
[TBL] [Abstract][Full Text] [Related]
36. Detection of AFPmRNA and melanoma antigen gene-1mRNA as markers of disseminated hepatocellular carcinoma cells in blood.
Yang SZ; Dong JH; Li K; Zhang Y; Zhu J
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):227-33. PubMed ID: 15908320
[TBL] [Abstract][Full Text] [Related]
37. [Discriminant function based on serum analyte for diagnosis of primary hepatic cancer].
Yi B; Luo JQ; Tang Y; Huang YD
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):373-5. PubMed ID: 12206007
[TBL] [Abstract][Full Text] [Related]
38. Are both PIVKA-II and alpha-fetoprotein necessary in follow-up management after hepatic resection for hepatocellular carcinoma?
Koh T; Taniguchi H; Katoh H; Kunishima S; Yamaguchi A; Yamagishi H
Hepatogastroenterology; 2002; 49(48):1615-8. PubMed ID: 12397748
[TBL] [Abstract][Full Text] [Related]
39. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
Yoon SK; Lim NK; Ha SA; Park YG; Choi JY; Chung KW; Sun HS; Choi MJ; Chung J; Wands JR; Kim JW
Cancer Res; 2004 Aug; 64(15):5434-41. PubMed ID: 15289352
[TBL] [Abstract][Full Text] [Related]
40. Clinical course of chronic hepatitis C in patients with very high serum alpha-fetoprotein levels and normal hepatic imaging.
Gonzalez SA; Jacobson IM
Am J Gastroenterol; 2005 Apr; 100(4):977-8. PubMed ID: 15784045
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]